Anti-CRF antibody [EPR23255-162]
- BOND RX™ Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal CRF antibody. Suitable for IHC-Fr, IHC-P and reacts with Mouse, Rat samples. Cited in 11 publications.
View Alternative Names
Corticoliberin, Corticotropin-releasing factor, Corticotropin-releasing hormone, CRF, CRH, CRH1, Corticoliberin, Corticotropin releasing factor, Corticotropin releasing hormone, Crh
- IHC-Fr
Unknown
Immunohistochemistry (Frozen sections) - Anti-CRF antibody [EPR23255-162] (AB272391)
Immunohistochemical analysis of 4% PFA-fixed, 0.2% Triton X-100 permeabilized frozen rat hypothalamus tissue labeling CRF with ab272391 at /100 dilution followed by ab150077 AlexaFluor®488 Goat anti-Rabbit secondary at 1000 (2 μg/ml) dilution (Green). Positive staining on median eminence of rat hypothalamus is observed. The nuclear counterstain was DAPI (Blue).
Secondary antibody control : Secondary antibody is ab150077 AlexaFluor®488 Goat anti-Rabbit secondaryat 1000 (2 μg/ml) dilution.
Heat mediated antigen retrieval using sodium citrate buffer (10mM citrate pH 6.0 + 0.05% Tween-20).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CRF antibody [EPR23255-162] (AB272391)
Immunohistochemical analysis of paraffin-embedded rat hypothalamus tissue labeling CRF with ab272391 at 1/1000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on rat hypothalamus is observed (PMID : 28883467). The section was incubated with ab272391 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
- IHC-Fr
Unknown
Immunohistochemistry (Frozen sections) - Anti-CRF antibody [EPR23255-162] (AB272391)
Immunohistochemical analysis of 4% PFA-fixed, 0.2% Triton X-100 permeabilized frozen mouse hypothalamus tissue labeling CRF with ab272391 at /100 dilution followed by ab150077 AlexaFluor®488 Goat anti-Rabbit secondary at 1000 (2 μg/ml) dilution (Green). Positive staining on median eminence of mouse hypothalamus is observed. The nuclear counterstain was DAPI (Blue).
Secondary antibody control : Secondary antibody is ab150077 AlexaFluor®488 Goat anti-Rabbit secondaryat 1000 (2 μg/ml) dilution.
Heat mediated antigen retrieval using sodium citrate buffer (10mM citrate pH 6.0 + 0.05% Tween-20).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CRF antibody [EPR23255-162] (AB272391)
Immunohistochemical analysis of paraffin-embedded mouse hypothalamus tissue labeling CRF with ab272391 at 1/1000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on mouse hypothalamus is observed (PMID : 23724107). The section was incubated with ab272391 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
Related conjugates and formulations (8)
-
Anti-CRF antibody [EPR23255-162] - BSA and Azide free
-
578 PE
PE Anti-CRF antibody [EPR23255-162]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CRF antibody [EPR23255-162]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CRF antibody [EPR23255-162]
-
660 APC
APC Anti-CRF antibody [EPR23255-162]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CRF antibody [EPR23255-162]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CRF antibody [EPR23255-162]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-CRF antibody [EPR23255-162]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Corticotropin-releasing factor functions as a central coordinator of the body's response to stress. CRF engages several receptors including CRF receptors type 1 and 2 which mediate its actions. It forms part of a larger complex involving several other binding proteins that regulate its availability and receptor affinity. By interacting with these receptors CRF modulates diverse physiological processes such as immune responses and energy balance ensuring the maintenance of homeostasis under stress conditions.
Pathways
Corticotropin-releasing factor orchestrates important signaling within the hypothalamic-pituitary-adrenal (HPA) axis and the stress response pathways. CRF is pivotal in the activation of various signaling cascades that influence the production of glucocorticoids like cortisol. Within these pathways CRF interacts closely with proteins such as ACTH which acts downstream of CRF to potentiate adrenal corticosteroid synthesis. Another related cascade involves CRF in neuroendocrine signaling affecting neurotransmitter release and influencing behaviors related to stress and anxiety.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Molecular psychiatry : PubMed41053436
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:8870 PubMed41053178
2025
Applications
Unspecified application
Species
Unspecified reactive species
World journal of psychiatry 15:107342 PubMed40837817
2025
Applications
Unspecified application
Species
Unspecified reactive species
Endocrinology 166: PubMed40302251
2025
Applications
Unspecified application
Species
Unspecified reactive species
eLife 12: PubMed39526880
2024
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 24:e57176 PubMed37870400
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:5601 PubMed37699899
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research communications 3:1524-1537 PubMed37575281
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of physiology 601:2853-2875 PubMed37154244
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 299:102728 PubMed36410433
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com